FRANCIS COLLINS

The Biden administration is seeking billions of dollars for a new push to wipe out hepatitis C, a virus that kills thousands of people annually in the U.S.

Nicholas Wade, a former science editor at the New York Times, criticized Dr. Anthony Fauci on Wednesday for mishandling issues surrounding COVID-19 origins.

Majority staff from the House Select Subcommittee on the Coronavirus Pandemic said via memo Dr. Fauci "prompted" the drafting of a publication that would "disprove" the lab leak theory.

Committee chairman raises prospects of subpoenas for Dr. Anthony Fauci, NIH Director Dr. Francis Collins, HHS Secretary Xavier Becerra.

Fox News Digital first obtained letters from the House Select Subcommittee on the Coronavirus Pandemic to Biden admin officials demanding documents and testimony on COVID origins.

As an evangelical Christian, the retiring N.I.H. director has built bridges across America’s cultural divide. Have they burned?

Francis Collins will serve as science adviser to the president, and Alondra Nelson will temporarily lead the Office of Science and Technology Policy until permanent leadership is named.

President Joe Biden is replacing a top science adviser who resigned under a cloud with two individuals who will split his positions on an interim basis.

American scientists who publicly attributed the COVID-19 pandemic to natural origins rather than human engineering were far less confident in private, transcripts and notes from previous meetings show.

Leading British and US scientists thought it was likely that Covid accidentally leaked from a laboratory but were concerned that further debate would harm science in China, emails show.

Whether done once a week or every day, this practice merges mindfulness and exercise.

"What we've seen in South Africa in particular, is a decoupling between the cases and hospitalizations," Gottlieb said.

Outgoing National Institutes of Health Director Dr. Francis Collins took aim at the makers of the 'The Great Barrington Declaration,' refusing to step down from calling them “'fringe epidemiologists' while arguing 'hundreds of thousands' would have died of COVID-19 if the country followed their advice

The virus is the enemy, NIH Director Francis Collins said. "It's not the other people in the other political party." Omicron, which could soon become the dominant strain, is extremely infectious.

The Massachusetts Democrat said she was experiencing only mild symptoms.

According to the governor's office, there were 21,908 COVID-19 cases reported the day before throughout the state, a record.

"What we've seen in South Africa in particular, is a decoupling between the cases and hospitalizations," Gottlieb said.

The Omicron variant could drive the U.S. toward U.S. hitting a million COVID-19 cases per day if Americans are not vigilant about mitigation strategies, outgoing National Institutes of Health director Francis Collins warned on NPR's "Weekend Edition" Sunday.Driving the news: The variant has been detected in 89 countries and is driving COVID-19 cases to double every 1.5 to 3 days in areas where there is community spread, according to the World Health Organization.Stay on top of the latest market

The following is a transcript of an interview with Dr. Francis Collins, director of the National Institutes of Health, that aired Sunday, December 19, 2021, on "Face the Nation."

Collins is retiring after 12 years of leading the federal health agency. He parts with a warning about the dangers of yielding to pandemic fatigue. "The virus is not tired of us," he says.

A look at the features for this week's broadcast of the #1 Sunday morning news program

Preview: Head of National Institutes of Health tells "CBS Sunday Morning" he tried staying out of partisan debates over last administration's coronavirus response, but was willing to quit rather than compromise scientific principles under former president.

The first full year of the biggest vaccination drive in American history has saved many lives but has left many behind.

As he prepares to leave his post of 12 years, Francis Collins reflects on the agency's biomedical advances, the dangers of polarizing medicine, and the huge health gaps that still exist in the U.S.

It seems like nothing will slow the surge of traveling lately, but health leaders are hoping that doesn’t equal a surge in COVID cases – specifically eyeing up the omicron variant.

To protect yourself against the omicron variant, experts say to do what you would against any other variant.

The director for the National Institutes of Health, says omicron appears to be a different animal entirely.

South African President Cyril Ramaphosa called the restrictions "completely unjustified."

While investigations continue into the Omicron variant, WHO recommends that all countries "take a risk-based and scientific approach and put in place measures which can limit its possible spread."

Japan announced Monday it will suspend entry of all foreign visitors from around the world as a new coronavirus variant spreads, prompting an increasing number of countries to tighten their borders. “We are taking the step as an emergency precaution to prevent a worst-case scenario in Japan,” Prime Minister Fumio Kishida said. The decision means Japan will restore border controls that it eased earlier this month for short-term business visitors, foreign students and workers.

While investigations continue into the Omicron variant, WHO recommends that all countries "take a risk-based and scientific approach and put in place measures which can limit its possible spread."

The World Health Organization has urged countries not to impose flight bans on southern African nations due to concerns over the new omicron variant.

The omicron variant has not been detected in the U.S., but Dr. Anthony Fauci says it is certain to be at some point. Fauci and Dr. Francis Collins appealed for people to get vaccinated as a defense.

Cases of the omicron variant of the coronavirus popped up in countries on opposite sides of the world Sunday and many governments rushed to close their borders.

NIH Director Dr. Francis Collins cited data from Israel that showed the waning effectiveness of Pfizer's Covid vaccine against the delta variant.

Collins is the first presidentially appointed NIH director to serve in more than one administration.

Collins has been director of the National Institutes of Health since 2019 and served under three U.S. presidents. NIH is the largest funder of basic and clinical biomedical research in the world.

Collins has led the agency for more than a decade.

NIH director called Israel's data on Covid-19 booster shots "impressive," saying it shows a tenfold reduction in infection for people who received a third dose.

Pfizer and BioNTech's trials for the COVID-19 vaccine for children under 12 showed the shots are safe for children and establish a strong antibody response against the virus.

Pfizer and BioNTech's trials for the COVID-19 vaccine for children under 12 showed the shots are safe for children and establish a strong antibody response against the virus.

Hundreds of demonstrators have marched in the streets of Australia’s second-largest city to protest mandatory coronavirus vaccine rules in the construction industry.

On this "Face the Nation" broadcast, Dr. Francis Collins and Senator Bernie Sanders join Margaret Brennan.

The National Institutes of Health director says a U_S_ government advisory panel’s decision to limit Pfizer COVID-19 booster shots to Americans 65 and older as well as those at high risk of severe disease is a preliminary step and predicts broader approval for most Americans “in the next few weeks.”.

A FDA panel on Friday declined to recommend booster shots for the general public.

The following is a transcript of an interview with Dr. Francis Collins, the director of the National Institutes of Health, that aired on Sunday, September 19, 2021, on "Face the Nation."

Some COVID-19 "long-haulers" report struggling with debilitating symptoms for months after their initial infection.

Alaska’s state epidemiologist says Alaska is experiencing “one of the sharpest surges” in COVID-19 in the country.

Some COVID-19 "long-haulers" report struggling with debilitating symptoms for months after their initial infection.

WASHINGTON — The U.S. intelligence community said Thursday that it was divided over the exact origin of Covid-19 in China. "After examining all available intelligence reporting and other information, though, the IC remains divided on the most likely origin of Covid-19. Four agencies said they had low confidence that the virus had a natural emergence, according to the report. In May, President Joe Biden ordered a closer intelligence review of what he described as two likely scenarios of the origins of the Covid-19. "Not to say that it could not have been under study secretly at the Wuhan Institute of Virology and got out of there, we don't know about that.

About three months ago, President Joe Biden gave the U.S. intelligence community 90 days to investigate Covid's origins and report the findings.

Just as school doors are reopening across the U.S., children are filling hospital beds instead of classrooms in record numbers, sick with COVID-19.

U.S. agencies are preparing to offer booster shots to all eligible Americans beginning the week of Sept. 20.

We look at the science behind the need for COVID-19 booster shots.

Israel data shows a reduction in the effectiveness of Pfizer's Covid vaccine against severe illness among people 65 and older who were fully vaccinated.

After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots.

The first group to receive them would likely be health care workers, nursing home residents and other older Americans.

New Zealand has detected its first community transmission of the coronavirus in months, triggering urgent meetings among top lawmakers.

The highly infectious Delta variant has been rapidly spreading amongst Americans with low vaccination rates, especially in Southern states.

Director of National Institutes of Health pleads with Americans to get their shots as Delta variant ravages the country Dr Francis Collins, director of the US National Institutes of Health (NIH), center, speaks during a Senate hearing in Washington on 26 May 2021. Photograph: Stefani Reynolds/EPA The US could soon see Covid-19 cases return to 200,000 a day, a level not seen since among the pandemic’s worst days in January and February, the director of the National Institutes of Health warned on

The director of the National Institutes of Health is warning of tough days ahead amid surging COVID-19 infections.

The district will require everyone to wear masks on school properties.

National Institutes of Health director says 1,450 kids in hospital Teachers union shifts, calls for vaccine mandates for teachers NIH director Francis Collins holds up a model of the coronavirus as he testifies before a Senate appropriations subcommittee on Capitol Hill on 26 May 2021. Photograph: REX/Shutterstock Amid increased fears that children are now both victims and vectors of the latest Covid-19 variant surge, National Institutes of Health director Francis Collins signaled on Sunday that

The U.S. government’s top infectious disease expert, Dr. Anthony Fauci, says he's hopeful that the Food and Drug Administration will give full approval to the coronavirus vaccine by month’s end.

The nation’s top infectious disease expert is warning that more “pain and suffering” is ahead as COVID-19 cases climb again and officials plead with unvaccinated Americans to get inoculated.

Federal prosecutors in Maryland say a man has been arrested and charged with sending emails that threatened to harm and kill Dr. Anthony Fauci, National Institutes of Health Director Dr. Francis Collins, and their families.

While reports of athletes, lawmakers and others occasionally getting the coronavirus despite vaccination may sound alarming, top health experts point to overwhelming evidence that the shots dramatically reduce severe disease and death.

Once dismissed by most public health experts and government officials, the hypothesis that COVID-19 leaked from a Chinese lab is now receiving scrutiny under a new U.S. investigation.

Renowned conservationist Jane Goodall has been named as this year’s winner of the prestigious Templeton Prize, honoring individuals whose life’s work embodies a fusion of science and spirituality.

A top White House aide is making his pitch for young people to get vaccinated personal by sharing the struggles his own son has dealt with since contracting COVID-19 last fall.

One year ago, no treatments had proved safe and effective for COVID-19, but that's not the case today.

Patricia Hailes Fears, pastor of the Fellowship Baptist Church in Washington, is administered with the Johnson & Johnson COVID-19 vaccine during a gathering of a group of interfaith clergy members, community leaders and officials at the Washington National Cathedral, to encourage faith communities to get the COVID-19 vaccine, Tuesday, March 16, 2021, in Washington. AdFollowing a moment of prayer for COVID-19 victims, the socially distanced attendees applauded when the Rev. Ad“We often get asked, can you get COVID-19 from the vaccine? It is impossible to get COVID-19 from the vaccine," Fauci said, sporting a gray face mask with drawings of laboratory beakers. In Washington, Black residents account for a little under half the population but nearly three-fourths of COVID-19 deaths.

The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. The J&J vaccine also is easier to handle, lasting three months in the refrigerator compared to the Pfizer and Moderna options, which must be frozen. Like other COVID-19 vaccines, the main side effects of the J&J shot are pain at the injection site and flu-like fever, fatigue and headache. All COVID-19 vaccines train the body to recognize the new coronavirus, usually by spotting the spikey protein that coats it. It’s the same technology the company used in making an Ebola vaccine, and similar to COVID-19 vaccines made by AstraZeneca and China’s CanSino Biologics.

President Joe Biden speaks during a visit to the Viral Pathogenesis Laboratory at the National Institutes of Health, Thursday, Feb. 11, 2021, in Bethesda, Md. – President Joe Biden said Thursday that the U.S. will have enough supply of the COVID-19 vaccine by the end of the summer to inoculate 300 million Americans. He toured the Viral Pathogenesis Laboratory that created the COVID-19 vaccine now manufactured by Moderna and being rolled out in the U.S. and other countries. The U.S. is on pace to exceed Biden’s goal of administering 100 million vaccine doses in his first 100 days in office, with more than 26 million shots delivered in his first three weeks. On the tour, Biden was shown the lab bench where researchers sequenced the virus and developed the precursor of the Moderna vaccine.

Lander added that Biden has tasked his advisers and “the whole scientific community and the American public” to “rise to this moment." Biden also named two prominent female scientists to co-chair the President's Council of Advisors on Science and Technology. Biden picked Alondra Nelson of the Institute for Advanced Study in Princeton, New Jersey, a social scientist who studies science, technology and social inequality, as deputy science policy chief. The president-elect noted the team's diversity and repeated his promise that his administration's science policy and investments would target historically disadvantaged and underserved communities. The job as director of science and technology policy requires Senate confirmation.

President-elect Joe Biden picked a pioneering geneticist to be his science advisor and elevated the job to his Cabinet. Saying “science will always be at the forefront of my administration,” Biden said he is boosting the science advisor post to Cabinet level, a first in White House history. The job as director of science and technology policy requires Senate confirmation. Science organizations were also quick to praise Lander and the promotion of the science post. Biden chose Alondra Nelson of the Institute for Advanced Study in Princeton, New Jersey, a social scientist who studies science, technology and social inequality, as deputy science policy chief.

The U.S. is poised to give the green light as early as Friday, Dec. 18, to a second COVID-19 vaccine, a critical new weapon against the surging coronavirus. The move marks the world’s first authorization for Moderna’s shots. FDA’s decision could help pave the way for other countries that are considering the Moderna vaccine, the first-ever regulatory clearance for the small Cambridge, Massachusetts, company. Injections of health workers and nursing home residents continue next week, before other essential workers and vulnerable groups are allowed to get in line. But there was a hint that Moderna’s shot might provide some protection against asymptomatic infection.

FDA’s decision could help pave the way for other countries that are considering the Moderna vaccine, the first-ever regulatory clearance for the small Cambridge, Massachusetts, company. Britain, Canada and a few other countries already have cleared the Pfizer-BioNTech shot, with a European Union decision due Monday. The FDA’s main messages:--Both the new Moderna vaccine and the Pfizer-BioNTech shot require two doses several weeks apart. --In a study of 30,000 volunteers, the Moderna vaccine was more than 94% effective at preventing symptomatic COVID-19 in people 18 and older. Like with the Pfizer-BioNTech shot, expect sore arms, fever, fatigue and muscle aches, which are signs the immune system is revving up.

“Relieved,” proclaimed critical care nurse Sandra Lindsay after becoming one of the first to be inoculated at Long Island Jewish Medical Center in New York. “I feel like healing is coming.”With a countdown of “3-2-1,” workers at Ohio State University's Wexner Medical Center gave initial injections to applause. It just represents a moral failing,” said Jennifer Nuzzo, a public health researcher at Johns Hopkins. Getting vaccinated is “a privilege,” said Dr. Leonardo Seoane, chief academic officer at Ochsner Health in suburban New Orleans, after getting his dose. And later this week, the FDA will decide whether to green-light the world’s second rigorously studied COVID-19 vaccine, made by Moderna Inc.

The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives. Kids with the genetic disorder progeria typically die in their early teens, usually from heart disease. But in testing, children taking the drug Zokinvy lived 2 1/2 years longer on average. Research on the treatment was mainly funded by the Progeria Research Foundation in Peabody, Massachusetts, with help from drug developer Eiger BioPharmaceuticals. The FDA action was based on two studies in which a total of 62 kids took the drug twice a day.

Moderna Inc. and competitor Pfizer Inc. recently announced preliminary results showing their vaccines appear more than 90% effective, at least for short-term protection against COVID-19. Instead, the vaccines are made with a brand-new technology that injects a piece of genetic code for the spike protein. TROJAN HORSE VACCINESA different way to target the spike protein: Use another, harmless virus to carry the spike gene into the body. Once again, the body produces some spike protein and primes the immune system. But inactivated vaccines give the body a sneak peek at the germ itself rather than just that single spike protein.

We can’t take another hit.”___MIAMI - Florida has reported a slight uptick in daily confirmed COVID-19 cases, adding 3,449 to its total caseload on Friday. There were 3,861 new coronavirus cases reported in Wisconsin on Friday, breaking the previous record set just a day earlier of 3,747. The report, released Friday by the Centers for Disease Control and Prevention, looks at coronavirus-associated deaths reported between May 1 and August 31. The deaths reported Friday include 10 women and eight men, all in their 60s or older. With 222 deaths reported in the last 24 hours, Spain’s total has reached 33,775.

French scientist Emmanuelle Charpentier and American Jennifer A. Doudna have won the Nobel Prize 2020 in chemistry for developing a method of genome editing likened to 'molecular scissors' that offer the promise of one day curing genetic diseases. “There is enormous power in this genetic tool,” said Claes Gustafsson, chair of the Nobel Committee for Chemistry. In 1911, Marie Curie was the sole recipient of the chemistry award, as was Dorothy Crowfoot Hodgkin in 1964. ___Read more stories about Nobel Prizes past and present by The Associated Press at https://www.apnews.com/NobelPrizes___This story was first published Oct. 7, 2020. It was updated on Oct. 8, 2020, to correct the aim of clinical trials that are underway with the gene-editing tool CRISPR.

Several drugs have proved useful and doctors know more about how to care for the sickest patients in hospitals, he said. People who have died from COVID-19, especially ones who took part in studies, have helped reveal what drugs do or do not help. Two anti-inflammatory drugs, one used in combination with remdesivir — the drug Wang helped test — also have been reported to help although results of those studies have not yet been published. In hospitals, doctors know more now about ways to avoid using breathing machines, such as keeping patients on their bellies. “Prevention is the most important step right now as we’re waiting for a vaccine and we’re improving treatment,” Goodman said.

This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. Johnson & Johnson is beginning a huge final study to try to prove if the single-dose vaccine can protect against the coronavirus. (Cheryl Gerber/Courtesy of Johnson & Johnson via AP)Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. U.S. health officials insist the race for a vaccine isn't cutting corners. J&J's vaccine is made with slightly different technology than others in late-stage testing, modeled on an Ebola vaccine the company created.

– In front of baskets of tomatoes and peppers, near a sizzling burrito grill, the “promotoras” stop masked shoppers at a busy Latino farmers market: Want to test a COVID-19 vaccine? Many thousands of volunteers from minority groups are needed for huge clinical trials underway or about to begin. Scientists say a diverse group of test subjects is vital to determining whether a vaccine is safe and effective for everyone and instilling broad public confidence in the shots once they become available. Together they make up nearly 40% of the U.S. population, and an equitable vaccine study would match those demographics, though health officials would like to see even greater numbers. —-The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education.

But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans. DOING THE MATHThe FDA already has told manufacturers it won't consider any vaccine that's less than 50% effective. On the other hand, if equal numbers from the vaccine and placebo groups got infected, the DSMB might declare a vaccine futile, he told The Associated Press. These panels also can calculate infections even before that 150 threshold is met, at set time points in each study. Several vaccine candidates made by Chinese companies are in late stages of testing in various countries, but with smaller numbers of volunteers.

AstraZeneca announced Monday its vaccine candidate has entered the final testing stage in the U.S. Final testing, experts stress, must be in large numbers of people to know if theyre safe enough for mass vaccinations. Instead, theyre made with the genetic code for the aptly named spike protein that coats the surface of the coronavirus. Chinas government authorized emergency use of CanSino Biologics adenovirus shots in the military ahead of any final testing. Competitor SinoPharm has announced plans for final testing in some other countries.

Houston Methodist Hospital is one such site conducting clinical trials and doctors there say recent results have shown promise. If you look at 28 days post-transfusion of the plasma, there is a significant reduction in mortality and death in those patients who received the plasma, Musser said. Despite the optimistic results from trials across the country, the Emergency Use Authorization of blood plasma as a treatment by the FDA is on hold, according to a New York Times article. It just means at this point the FDA wants additional information, said Dr. Musser. Although the Emergency Use Authorization is on hold for now, that is not to say things couldnt change after more data is collected.

Who gets to be first in line for a COVID-19 vaccine? Huge studies this summer aim to prove which of several experimental COVID-19 vaccines are safe and effective. But a COVID-19 vaccine decision is so tricky that this time around, ethicists and vaccine experts from the National Academy of Medicine, chartered by Congress to advise the government, are being asked to weigh in, too. Indeed, the risks for health workers today are far different than in the pandemics early days. Now, health workers in COVID-19 treatment units often are the best protected; others may be more at risk, committee members noted.